Literature DB >> 30546162

Captive to the Clinic: Phase I Clinical Trials as Temporal Total Institutions.

Quintin Williams, Jill A Fisher.   

Abstract

This article develops the concept of temporal total institutions to describe how and why individuals voluntarily submit to highly-controlled and often dehumanizing environments. We focus empirically on Phase I clinical trials, which offer compensation to healthy people in exchange for testing investigational pharmaceuticals. Analyzing the experiences of 67 U.S. healthy volunteers, we illustrate how comparisons between Phase I trials and prison are salient to participants as they reflect on their confinement in research facilities and their interactions with other participants and research staff. We argue that conditions of contemporary economic insecurity and/or poverty facilitate the existence of coercive temporal total institutions by undermining voluntariness. Phase I clinics take advantage of the steady supply of individuals who will submit to the organization's demands out of hope that the income gained will be transformative for their lives.

Entities:  

Keywords:  Race; class; clinical trials; poverty; prison; total institution

Year:  2018        PMID: 30546162      PMCID: PMC6287918          DOI: 10.1111/soin.12228

Source DB:  PubMed          Journal:  Sociol Inq        ISSN: 0038-0245


  16 in total

1.  Inducement in research.

Authors:  Martin Wilkinson; Andrew Moore
Journal:  Bioethics       Date:  1997-10       Impact factor: 1.898

2.  Challenging assumptions about minority participation in US clinical research.

Authors:  Jill A Fisher; Corey A Kalbaugh
Journal:  Am J Public Health       Date:  2011-10-20       Impact factor: 9.308

3.  Guinea-pigging: healthy human subjects for drug safety trials are in demand. But is it a living?

Authors:  Carl Elliott
Journal:  New Yorker       Date:  2008-01-07

4.  Exploitation in payments to research subjects.

Authors:  Trisha Phillips
Journal:  Bioethics       Date:  2011-05       Impact factor: 1.898

5.  Using "clinical trial diaries" to track patterns of participation for serial healthy volunteers in U.S. phase I studies.

Authors:  Heather B Edelblute; Jill A Fisher
Journal:  J Empir Res Hum Res Ethics       Date:  2015-01-20       Impact factor: 1.742

6.  Feeding and Bleeding: The Institutional Banalization of Risk to Healthy Volunteers in Phase I Pharmaceutical Clinical Trials.

Authors:  Jill A Fisher
Journal:  Sci Technol Human Values       Date:  2015-03-01

7.  'I'm still a hustler': entrepreneurial responses to precarity by participants in phase I clinical trials.

Authors:  Torin Monahan; Jill A Fisher
Journal:  Econ Soc       Date:  2016-01-06

8.  Recruitment of minority and underserved populations in the United States: the Centers for Population Health and Health Disparities experience.

Authors:  Electra D Paskett; Katherine W Reeves; John M McLaughlin; Mira L Katz; Ann Scheck McAlearney; Mack T Ruffin; Chanita Hughes Halbert; Cristina Merete; Faith Davis; Sarah Gehlert
Journal:  Contemp Clin Trials       Date:  2008-07-31       Impact factor: 2.226

9.  Balancing justice and autonomy in clinical research with healthy volunteers.

Authors:  N E Kass; R Myers; E J Fuchs; K A Carson; C Flexner
Journal:  Clin Pharmacol Ther       Date:  2007-04-04       Impact factor: 6.875

10.  Serial Participation and the Ethics of Phase 1 Healthy Volunteer Research.

Authors:  Rebecca L Walker; Marci D Cottingham; Jill A Fisher
Journal:  J Med Philos       Date:  2018-01-12
View more
  4 in total

1.  Speculating on Precarious Income: Finance Cultures and the Risky Strategies of Healthy Volunteers in Clinical Drug Trials.

Authors:  Jill A Fisher; Megan M Wood; Torin Monahan
Journal:  J Cult Econ       Date:  2020-12-21

2.  Advancing Ethics and Policy for Healthy-Volunteer Research through a Model-Organism Framework.

Authors:  Jill A Fisher; Rebecca L Walker
Journal:  Ethics Hum Res       Date:  2019-01

3.  Healthy volunteers in US phase I clinical trials: Sociodemographic characteristics and participation over time.

Authors:  Corey A Kalbaugh; Julianne M Kalbaugh; Lisa McManus; Jill A Fisher
Journal:  PLoS One       Date:  2021-09-07       Impact factor: 3.240

4.  Commentary on Zvonareva et al.: Exploring the many meanings of "professional" in research participation.

Authors:  Jill A Fisher
Journal:  Clin Trials       Date:  2019-10-05       Impact factor: 2.486

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.